| 辽藁本抗动脉粥样硬化的实验研究 |
| |
| 引用本文： | 张昭华,庞敏,刘晶,武晓琳,刘禾. 辽藁本抗动脉粥样硬化的实验研究[J]. 中华中医药学刊, 2020, 0(3): 78-80,I0017 |
| |
| 作者姓名： | 张昭华 庞敏 刘晶 武晓琳 刘禾 |
| |
| 作者单位： | 辽宁中医药大学;辽宁省中医药研究院 |
| |
| 基金项目： | 十二五国家科技重大专项“重大新药创制”(2102ZX09303-017-001);辽宁省自然科学基金指导计划(201602441)。 |
| |
| 摘 要： | 目的评价辽藁本对动脉粥样硬化模型兔血脂、C反应蛋白等指标的调节能力,探讨其抗动脉粥样硬化的可能作用机制。方法采用免疫损伤法、球囊手术法、高脂饲料饲养法共同完成动脉粥样硬化动物模型,检测血脂指标、C反应蛋白、HE染色观察颈总动脉血管内皮组织病理形态学变化。结果辽藁本临床4倍等效剂量组(1.88 g生药/kg)与模型组比较,能够显著降低TC、LDL、C反应蛋白水平(P<0.05),辽藁本给药组显著改善白兔病理学形态学变化。结论辽藁本能够通过调节血脂、降低C反应蛋白,发挥抗动脉粥样硬化作用。
|
| 关 键 词： | 兔 动脉粥样硬化 辽藁本 |
Experimental Study on Anti Atherosclerosis of Ligusticum jeholense |
| |
| ZHANG Zhaohua,PANG Min,LIU Jing,WU Xiaolin,LIU He. Experimental Study on Anti Atherosclerosis of Ligusticum jeholense[J]. Chinese Archives of Traditional Chinese Medicine, 2020, 0(3): 78-80,I0017 |
| |
| Authors: | ZHANG Zhaohua PANG Min LIU Jing WU Xiaolin LIU He |
| |
| Affiliation: | (Liaoning University of Traditional Chinese Medicine,Shenyang 110847,Liaoning,China;Liaoning Institute of Traditional Chinese Medicine,Shenyang 110034,Liaoning,China) |
| |
| Abstract: | Objective To evaluate the regulatory ability of Ligusticum jeholense on blood lipid, C-reactive protein and other indexes in atherosclerotic model rabbits and explore the possible mechanism of its anti-atherosclerotic effect.Methods The atherosclerotic animal model was established by immune injury method, balloon surgery method and high-fat feed method. The changes of blood lipid, C-reactive protein and HE staining were observed.Results Compared with the model group, the levels of TC, LDL and C-reactive protein in the 4 times equivalent dose of Ligusticum jeholense group(1.88 g crude medicine/kg) was significantly reduced(P<0.05).The pathological and morphological changes were significantly improved in the treatment group.Conclusion Ligusticum jeholense can play an anti-atherosclerotic role by regulating blood lipid and reducing C-reactive protein. |
| |
| Keywords: | rabbit atherosclerosis Ligusticum jeholense |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
